Salivary Gland Adenocarcinoma — Trials

Salivary Gland Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: LMU Klinikum
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04249947	P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)	terminated	Phase 1	40	Poseida Therapeutics, Inc.INDUSTRY	1	Feb 17, 2025	clinicaltrials
NCT00126607	Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer	terminated	Phase 2	35	National Cancer Institute (NCI)NIH	1	Feb 28, 2013	clinicaltrials